Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Cell Rep ; 43(2): 113688, 2024 Feb 27.
Artigo em Inglês | MEDLINE | ID: mdl-38245869

RESUMO

Macrophages are phenotypically and functionally diverse in the tumor microenvironment (TME). However, how to remodel macrophages with a protumor phenotype and how to manipulate them for therapeutic purposes remain to be explored. Here, we show that in the TME, RARγ is downregulated in macrophages, and its expression correlates with poor prognosis in patients with colorectal cancer (CRC). In macrophages, RARγ interacts with tumor necrosis factor receptor-associated factor 6 (TRAF6), which prevents TRAF6 oligomerization and autoubiquitination, leading to inhibition of nuclear factor κB signaling. However, tumor-derived lactate fuels H3K18 lactylation to prohibit RARγ gene transcription in macrophages, consequently enhancing interleukin-6 (IL-6) levels in the TME and endowing macrophages with tumor-promoting functions via activation of signal transducer and activator of transcription 3 (STAT3) signaling in CRC cells. We identified that nordihydroguaiaretic acid (NDGA) exerts effective antitumor action by directly binding to RARγ to inhibit TRAF6-IL-6-STAT3 signaling. This study unravels lactate-driven macrophage function remodeling by inhibition of RARγ expression and highlights NDGA as a candidate compound for treating CRC.


Assuntos
Neoplasias Colorretais , Interleucina-6 , Humanos , Carcinogênese/metabolismo , Transformação Celular Neoplásica/metabolismo , Neoplasias Colorretais/patologia , Histonas/metabolismo , Interleucina-6/metabolismo , Lactatos/metabolismo , Macrófagos/metabolismo , Fator de Transcrição STAT3/metabolismo , Fator 6 Associado a Receptor de TNF/metabolismo , Microambiente Tumoral
2.
Biomed Pharmacother ; 165: 115261, 2023 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-37549461

RESUMO

Enhancing the clearance of proteins associated with Alzheimer's disease (AD) emerges as a promising approach for AD therapeutics. This study explores the potential of Radix Stellariae, a traditional Chinese medicine, in treating AD. Utilizing transgenic C. elegans models of AD, we demonstrated that a 75% ethanol extract of Radix Stellariae (RSE) (at 50 µg/mL) effectively diminishes Aß and Tau protein expression, and alleviates their induced impairments including paralysis, behavioral dysfunction, neurotoxicity, and ROS accumulation. Additionally, RSE enhances the stress resistance of C. elegans. Further investigations revealed that RSE promotes autophagy, a critical cellular process for protein degradation, in these models. We found that inhibiting autophagy-related genes negated the neuroprotective effects of RSE, suggesting a central role for autophagy in the actions of RSE. In PC-12 cells, we observed that RSE not only inhibited Aß fibril formation but also promoted the degradation of AD-related proteins and reduced their cytotoxicity. Mechanistically, RSE was found to induce autophagy via modulating PI3K/AKT/mTOR and AMPK/mTOR signaling pathways. Importantly, inhibiting autophagy counteracted the beneficial effects of RSE on the clearance of AD-associated proteins. Moreover, we identified Dichotomine B, a ß-carboline alkaloid, as a key active constituent of RSE in mitigating AD pathology in C. elegans at concentrations ranging from 50 to 1000 µM. Collectively, our study presents novel discoveries that RSE alleviates AD pathology and toxicity primarily by inducing autophagy, both in vivo and in vitro. These findings open up new avenues for exploring the therapeutic potential of RSE and its active component, Dichotomine B, in treating neurodegenerative diseases like AD.


Assuntos
Doença de Alzheimer , Animais , Doença de Alzheimer/metabolismo , Caenorhabditis elegans/metabolismo , Fosfatidilinositol 3-Quinases , Autofagia , Serina-Treonina Quinases TOR , Peptídeos beta-Amiloides/metabolismo , Modelos Animais de Doenças
3.
Phytother Res ; 37(10): 4639-4654, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37394882

RESUMO

BACKGROUND: Alzheimer's disease (AD) is a prevalent neurodegenerative disorder without an effective cure. Natural products, while showing promise as potential therapeutics for AD, remain underexplored. AIMS: This study was conducted with the goal of identifying potential anti-AD candidates from natural sources using Caenorhabditis elegans (C. elegans) AD-like models and exploring their mechanisms of action. MATERIALS & METHODS: Our laboratory's in-house herbal extract library was utilized to screen for potential anti-AD candidates using the C. elegans AD-like model CL4176. The neuroprotective effects of the candidates were evaluated in multiple C. elegans AD-like models, specifically targeting Aß- and Tau-induced pathology. In vitro validation was conducted using PC-12 cells. To investigate the role of autophagy in mediating the anti-AD effects of the candidates, RNAi bacteria and autophagy inhibitors were employed. RESULTS: The ethanol extract of air-dried fruits of Luffa cylindrica (LCE), a medicine-food homology species, was found to inhibit Aß- and Tau-induced pathology (paralysis, ROS production, neurotoxicity, and Aß and pTau deposition) in C. elegans AD-like models. LCE was non-toxic and enhanced C. elegans' health. It was shown that LCE activates autophagy and its anti-AD efficacy is weakened with the RNAi knockdown of autophagy-related genes. Additionally, LCE induced mTOR-mediated autophagy, reduced the expression of AD-associated proteins, and decreased cell death in PC-12 cells, which was reversed by autophagy inhibitors (bafilomycin A1 and 3-methyladenine). DISCUSSION: LCE, identified from our natural product library, emerged as a valuable autophagy enhancer that effectively protects against neurodegeneration in multiple AD-like models. RNAi knockdown of autophagy-related genes and cotreatment with autophagy inhibitors weakened its anti-AD efficacy, implying a critical role of autophagy in mediating the neuroprotective effects of LCE. CONCLUSION: Our findings highlight the potential of LCE as a functional food or drug for targeting AD pathology and promoting human health.


Assuntos
Doença de Alzheimer , Proteínas de Caenorhabditis elegans , Luffa , Fármacos Neuroprotetores , Animais , Humanos , Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/metabolismo , Caenorhabditis elegans/genética , Caenorhabditis elegans/metabolismo , Luffa/metabolismo , Peptídeos beta-Amiloides/metabolismo , Fármacos Neuroprotetores/farmacologia , Fármacos Neuroprotetores/uso terapêutico , Frutas/metabolismo , Autofagia , Modelos Animais de Doenças , Proteínas de Caenorhabditis elegans/genética , Proteínas de Caenorhabditis elegans/metabolismo , Proteínas de Caenorhabditis elegans/farmacologia
4.
Org Lett ; 24(6): 1394-1399, 2022 02 18.
Artigo em Inglês | MEDLINE | ID: mdl-35132855

RESUMO

An efficient copper-catalyzed asymmetric ring-opening reaction of diaryliodonium salts with imides has been developed, affording a wide range of axially chiral 2-imidobiaryl compounds with excellent enantioselectivities and better convertibility. The potential utility of the current method has been supported by the synthesis of two known chiral ligands with better efficiency, which would be of great significance to the development of other catalytic asymmetric reactions.

6.
Phys Med Biol ; 66(22)2021 11 15.
Artigo em Inglês | MEDLINE | ID: mdl-34715682

RESUMO

Neuroscience researches based on functional magnetic resonance imaging (fMRI) rely on accurate inter-subject image registration of functional regions. The intersubject alignment of fMRI can improve the statistical power of group analyses. Recent studies have shown the deep learning-based registration methods can be used for registration. In our work, we proposed a 30-Identity-Mapping Cascaded network (30-IMCNet) for rs-fMRI registration. It is a cascaded network that can warp the moving image progressively and finally align to the fixed image. A Combination unit with an identity-mapping path is added to the inputs of each IMCNet to guide the network training. We implemented 30-IMCNet on an rs-fMRI dataset (1000 Functional Connectomes Project dataset) and a task-related fMRI dataset (Eyes Open Eyes Closed fMRI dataset). To evaluate our method, a group-level analysis was implemented in the testing dataset. For rs-fMRI, the criterions such as peakt-value of group-level t-maps, cluster-level evaluation, and intersubject functional network correlation were used to evaluate the quality of the registrations. For task-related fMRI, peakt-value in ALFF paired-t map and peakt-value in ReHo paired-t maps were used. Compared with traditional algorithm FSL, SPM, and deep learning algorithm Kimet al, Zhaoet alour method has improvements of 48.90%, 30.73%, 36.38%, and 16.73% in the peaktvalue of t-maps. Our proposed method can achieve superior functional registration performance and thus gain a significant improvement in functional consistency.


Assuntos
Mapeamento Encefálico , Imageamento por Ressonância Magnética , Algoritmos , Encéfalo/diagnóstico por imagem , Mapeamento Encefálico/métodos , Processamento de Imagem Assistida por Computador , Imageamento por Ressonância Magnética/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA